Lesotho
Showing 1 - 25 of 49
Alcohol Use Disorder, Mild, Alcohol Use Disorder, Moderate Trial in Butha-Buthe, Mokhotlong (mhGAP-Remote, mhGAP-Standard)
Not yet recruiting
- Alcohol Use Disorder, Mild
- Alcohol Use Disorder, Moderate
- mhGAP-Remote
- mhGAP-Standard
-
Butha-Buthe, Butha Buthe, Lesotho
- +4 more
Jun 21, 2023
Type 2 Diabetes (T2D) Trial in Maseru, Basel (T2D care package, Referral to the responsible health facility)
Not yet recruiting
- Type 2 Diabetes Mellitus (T2D)
- T2D care package
- Referral to the responsible health facility
-
Maseru, Lesotho
- +1 more
Feb 14, 2023
Community-Based Chronic Disease Care in Rural Lesotho
Not yet recruiting
- Non-communicable Diseases (NCDs)
-
Maseru, Lesotho
- +1 more
Nov 29, 2022
Preconception Care Trial in Maseru (mHealth Application)
Active, not recruiting
- Preconception Care
- mHealth Application
-
Maseru, LesothoLesotho Boston Health Alliance
Aug 4, 2022
Strengthening Evidence on Optimal Multidrug-resistant
Recruiting
- Tuberculosis, Multidrug-Resistant
- HIV
- Bdq, Lzd, Lfx, Dlm, Cfz (9-12 months)
- +2 more
-
Almaty, Kazakhstan
- +2 more
May 12, 2023
HIV Trial in Butha-Buthe, Mokhotlong (VITAL model)
Active, not recruiting
- HIV Infections
- VITAL model
-
Butha-Buthe, Lesotho
- +17 more
May 2, 2022
HIV-1-infection Trial in Lesotho, Tanzania (Clinical management informed by HIV-1 genotypic resistance testing)
Active, not recruiting
- HIV-1-infection
- Clinical management informed by HIV-1 genotypic resistance testing
-
Seboche, Butha-Buthe, Lesotho
- +9 more
Dec 4, 2022
Tuberculosis Trial in Berea (Community-based intervention, Standard of care)
Completed
- Tuberculosis
- Community-based intervention
- Standard of care
-
Berea, Berea District, Lesotho
- +9 more
Apr 4, 2022
Arterial Hypertension Trial in Maseru, Basel (First-line antihypertensive single-pill combination (SPC), Standardized
Not yet recruiting
- Arterial Hypertension
- First-line antihypertensive single-pill combination (SPC)
- Standardized counselling and referral to the closest health facility
-
Maseru, Lesotho
- +1 more
Jan 13, 2023
The CATALYST Study
Recruiting
- HIV Prevention
-
Kisumu, Kenya
- +27 more
Jun 30, 2023
Tolerability of Lopinavir Versus Dolutegravir for Children and
Recruiting
- HIV
-
Maseru, Lesotho
- +1 more
Jul 25, 2022
HIV/AIDS Trial in Lesotho (switch)
Completed
- HIV/AIDS
- switch
-
Hlotse, Leribe, Lesotho
- +7 more
Mar 20, 2022
Human Immunodeficiency Virus (HIV) Infection Trial in Maseru, Blantyre (ART first- Therapeutic use trial, TB results first-
Recruiting
- Human Immunodeficiency Virus (HIV) Infection
- ART first- Therapeutic use trial
- TB results first- Therapeutic use trial
-
Maseru, Lesotho
- +1 more
Aug 10, 2022
Arterial Hypertension Trial in Mokhotlong, Basel, Ifakara (dual combination, triple combination, Standard of care)
Active, not recruiting
- Arterial Hypertension
- dual combination
- +2 more
-
Mokhotlong, Lesotho
- +2 more
Mar 30, 2022
Pharmacometrics to Advance Novel Regimens for Drug-resistant
Recruiting
- Multi-drug Resistant Tuberculosis
-
Almaty, Kazakhstan
- +6 more
Nov 1, 2022
Tuberculosis, HIV Trial in Lesotho (Combination Intervention Package, Standard of Care)
Completed
- Tuberculosis
- HIV
- Combination Intervention Package
- Standard of Care
-
Koali, Lesotho
- +11 more
Jul 12, 2021
HIV/AIDS Trial in Butha-Buthe, Leribe, Mokhotlong (PEBRA model)
Completed
- HIV/AIDS
- PEBRA model
-
Butha-Buthe, Lesotho
- +19 more
May 31, 2021
Patients Who Received Etravirine and/or Darunavir
Recruiting
- HIV/AIDS
-
Yaounde, Centre Region, Cameroon
- +4 more
Mar 22, 2022
Tuberculosis, Pediatric Trial in Worldwide (Innovative approached to pediatric TB care)
Completed
- Tuberculosis
- Pediatric
- Innovative approached to pediatric TB care
-
Djoungolo, Cameroon
- +9 more
Jul 21, 2022
HIV/AIDS Trial in Butha-Buthe, Mokhotlong (Standard of Care, Village-based ART refill)
Completed
- HIV/AIDS
- Standard of Care
- Village-based ART refill
-
Butha-Buthe, Lesotho
- +1 more
Mar 26, 2021
Expand New Drugs for TB [endTB]
Completed
- Tuberculosis, Multidrug-Resistant
- This is a non-intervention observational study
-
Abovyan, Armenia
- +15 more
Jun 9, 2022
Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Bedaquiline
- +7 more
-
Tbilisi, Georgia
- +11 more
Feb 14, 2022
Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG
Recruiting
- Tuberculosis, Multidrug-Resistant
- +5 more
- Bedaquiline 100 MG
- +4 more
-
Pune, India
- +9 more
Mar 2, 2022
Human Immunodeficiency Virus Trial (IMPROVE)
Completed
- Human Immunodeficiency Virus
- IMPROVE
- (no location specified)
Oct 19, 2020